Cartesian Therapeutics CVR
13F holders, Q1 2025 (March 31)3holders
0new positions
0sold out
$0.02avg. 13F price*
At the end of Q1 2025, 3 institutions reported holding Cartesian Therapeutics CVR in their 13F filings, unchanged from Q4 2024. 0 opened new positions and 0 sold out. The largest holders were Erste Asset Management GmbH ($61K), Sterling Capital Management LLC ($6K) and Ironwood Investment Management LLC ($0).
- Company
- Cartesian Therapeutics CVR
- CUSIP
- 816212112
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q4 2024 → Q1 2025: 350 shares sold, net −350 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| Erste Asset Management GmbH | 0.00% | No change | 2,527,000 | $61K |
| Sterling Capital Management LLC | 0.00% | No change | 8,268 | $6K |
| Ironwood Investment Management LLC | 0.00% | Reduce -0.2% | 173,645 | $0 |
"% of holder's portfolio" is Cartesian Therapeutics CVR's weight in each manager's 13F, not the share of Cartesian Therapeutics CVR the manager owns.